<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Automating PSUR/PBRER Generation: From Months to Days | ArcaScience</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <style>
        *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
            color: #1a1a2e;
            line-height: 1.7;
            font-size: 11pt;
            background: #ffffff;
        }

        .page-header {
            background: linear-gradient(135deg, #2563EB 0%, #1e40af 100%);
            color: #ffffff;
            padding: 60px 60px 50px;
        }

        .page-header .logo {
            font-size: 14pt;
            font-weight: 700;
            letter-spacing: 1.5px;
            text-transform: uppercase;
            margin-bottom: 30px;
            opacity: 0.9;
        }

        .page-header h1 {
            font-size: 26pt;
            font-weight: 700;
            line-height: 1.2;
            margin-bottom: 15px;
            max-width: 700px;
        }

        .page-header .subtitle {
            font-size: 13pt;
            font-weight: 300;
            opacity: 0.9;
            max-width: 600px;
        }

        .page-header .meta {
            margin-top: 25px;
            font-size: 9pt;
            opacity: 0.75;
        }

        .content {
            max-width: 760px;
            margin: 0 auto;
            padding: 50px 60px;
        }

        h2 {
            font-size: 18pt;
            font-weight: 700;
            color: #2563EB;
            margin-top: 40px;
            margin-bottom: 15px;
            padding-bottom: 8px;
            border-bottom: 2px solid #e5e7eb;
        }

        h3 {
            font-size: 13pt;
            font-weight: 600;
            color: #1e40af;
            margin-top: 25px;
            margin-bottom: 10px;
        }

        p {
            margin-bottom: 14px;
            text-align: justify;
        }

        .executive-summary {
            background: #f0f4ff;
            border-left: 4px solid #2563EB;
            padding: 25px 30px;
            margin: 30px 0;
            border-radius: 0 8px 8px 0;
        }

        .executive-summary h2 {
            margin-top: 0;
            border-bottom: none;
            padding-bottom: 0;
        }

        ul, ol {
            margin-bottom: 14px;
            padding-left: 25px;
        }

        li {
            margin-bottom: 6px;
        }

        .callout {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            padding: 20px 25px;
            margin: 20px 0;
        }

        .callout-title {
            font-weight: 600;
            color: #2563EB;
            margin-bottom: 8px;
        }

        .pain-point {
            display: flex;
            align-items: flex-start;
            margin: 12px 0;
            padding: 14px 18px;
            background: #fef2f2;
            border-radius: 8px;
            border-left: 4px solid #ef4444;
        }

        .pain-point .icon {
            flex-shrink: 0;
            width: 24px;
            margin-right: 12px;
            font-size: 14pt;
            line-height: 1.3;
        }

        .pain-point p {
            margin-bottom: 0;
        }

        .solution-point {
            display: flex;
            align-items: flex-start;
            margin: 12px 0;
            padding: 14px 18px;
            background: #f0fdf4;
            border-radius: 8px;
            border-left: 4px solid #22c55e;
        }

        .solution-point .icon {
            flex-shrink: 0;
            width: 24px;
            margin-right: 12px;
            font-size: 14pt;
            line-height: 1.3;
        }

        .solution-point p {
            margin-bottom: 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            font-size: 10pt;
        }

        th {
            background: #2563EB;
            color: #ffffff;
            padding: 10px 14px;
            text-align: left;
            font-weight: 600;
        }

        td {
            padding: 10px 14px;
            border-bottom: 1px solid #e5e7eb;
        }

        tr:nth-child(even) td {
            background: #f8fafc;
        }

        .pipeline-diagram {
            background: #f8fafc;
            border: 1px solid #e2e8f0;
            border-radius: 12px;
            padding: 25px;
            margin: 25px 0;
            text-align: center;
        }

        .pipeline-step {
            display: inline-block;
            background: #2563EB;
            color: #ffffff;
            padding: 10px 16px;
            border-radius: 6px;
            font-size: 9pt;
            font-weight: 600;
            margin: 5px;
            vertical-align: middle;
        }

        .pipeline-arrow {
            display: inline-block;
            color: #2563EB;
            font-size: 16pt;
            font-weight: 700;
            margin: 0 4px;
            vertical-align: middle;
        }

        .metric-box {
            display: inline-block;
            width: 30%;
            text-align: center;
            padding: 20px;
            margin: 10px 1%;
            background: #f0f4ff;
            border-radius: 8px;
        }

        .metric-box .number {
            font-size: 28pt;
            font-weight: 700;
            color: #2563EB;
        }

        .metric-box .label {
            font-size: 9pt;
            color: #64748b;
            margin-top: 5px;
        }

        .metrics-row {
            text-align: center;
            margin: 25px 0;
        }

        .cta-section {
            background: linear-gradient(135deg, #2563EB 0%, #1e40af 100%);
            color: #ffffff;
            padding: 35px;
            border-radius: 12px;
            margin: 40px 0 20px;
            text-align: center;
        }

        .cta-section h3 {
            color: #ffffff;
            font-size: 16pt;
            margin-bottom: 10px;
        }

        .cta-section p {
            text-align: center;
            opacity: 0.9;
        }

        .cta-section .cta-link {
            color: #ffffff;
            font-weight: 600;
            text-decoration: underline;
        }

        .page-footer {
            text-align: center;
            padding: 30px 60px;
            font-size: 8.5pt;
            color: #94a3b8;
            border-top: 1px solid #e5e7eb;
        }

        @media print {
            body { font-size: 10pt; }
            .page-header { padding: 40px; -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .content { padding: 30px 40px; }
            .cta-section { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .metric-box { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .executive-summary { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .pain-point { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .solution-point { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .pipeline-step { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            th { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            h2, h3 { page-break-after: avoid; }
            table, .callout, .pipeline-diagram { page-break-inside: avoid; }
        }
    </style>
</head>
<body>

<div class="page-header">
    <div class="logo">ArcaScience</div>
    <h1>Automating PSUR/PBRER Generation: From Months to Days</h1>
    <div class="subtitle">How AI-driven automation transforms periodic safety reporting while maintaining ICH E2C(R2) compliance</div>
    <div class="meta">Whitepaper | 2026 | arcascience.ai</div>
</div>

<div class="content">

    <div class="executive-summary">
        <h2>Executive Summary</h2>
        <p>
            Periodic Safety Update Reports (PSURs) and Periodic Benefit-Risk Evaluation Reports (PBRERs) are among the most resource-intensive regulatory obligations facing pharmaceutical companies. A single PBRER for a marketed product typically requires 12-20 weeks of effort from a team of 8-15 professionals, costing $500K-$1.2M per report. For companies with portfolios of 10-50 marketed products, the cumulative burden is substantial.
        </p>
        <p>
            This whitepaper demonstrates how AI-driven automation can reduce PBRER/PSUR preparation time by <strong>70-80%</strong>, improve consistency and quality, and enable a shift from reactive document production to proactive safety surveillance. We detail the data pipeline architecture, quality assurance mechanisms, and compliance considerations for automated periodic safety reporting.
        </p>
    </div>

    <h2>1. PSUR/PBRER Regulatory Requirements</h2>

    <p>
        The PBRER (known as PSUR in some jurisdictions) is a comprehensive assessment of a product's global benefit-risk balance, required at regular intervals throughout a product's market life. The current regulatory framework is defined by ICH E2C(R2), which establishes the content, format, and analytical expectations for these reports.
    </p>

    <h3>1.1 Key ICH E2C(R2) Requirements</h3>
    <p>
        The ICH E2C(R2) guideline specifies that a PBRER should contain:
    </p>
    <ul>
        <li><strong>Worldwide marketing authorization status</strong> and regulatory actions taken during the reporting interval</li>
        <li><strong>Estimated exposure data</strong> including patient-exposure and patient-time calculations from multiple sources</li>
        <li><strong>Presentation of individual case histories</strong> for serious, unlisted, or otherwise noteworthy adverse reactions</li>
        <li><strong>Summary tabulations</strong> of adverse reactions from clinical trials and spontaneous sources</li>
        <li><strong>Signal evaluation</strong> including new signals identified, ongoing assessments, and closed signals</li>
        <li><strong>Integrated benefit-risk analysis</strong> considering new efficacy/effectiveness information alongside the safety profile</li>
        <li><strong>Conclusions and actions</strong> including any proposed label changes or risk minimization measures</li>
    </ul>

    <h3>1.2 Submission Schedules</h3>
    <table>
        <thead>
            <tr>
                <th>Region</th>
                <th>Report Type</th>
                <th>Frequency</th>
                <th>Submission Timeline</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>EU (EMA)</td>
                <td>PSUR</td>
                <td>Per EURD list</td>
                <td>70 days after DLP</td>
            </tr>
            <tr>
                <td>US (FDA)</td>
                <td>PBRER</td>
                <td>Annual (first 3 years), then triennial</td>
                <td>60 days after anniversary</td>
            </tr>
            <tr>
                <td>Japan (PMDA)</td>
                <td>PSUR</td>
                <td>Semi-annual (first 2 years), then annual</td>
                <td>60 days after DLP</td>
            </tr>
            <tr>
                <td>ICH Harmonized</td>
                <td>PBRER</td>
                <td>Per birth date cycle</td>
                <td>70 days for single assessment</td>
            </tr>
        </tbody>
    </table>
    <p style="font-size: 9pt; color: #64748b; margin-top: -10px;">DLP = Data Lock Point; EURD = European Union Reference Dates</p>

    <h2>2. Current Manual Process Pain Points</h2>

    <p>
        Despite the critical importance of PBRERs, the preparation process remains largely manual in most organizations, creating significant operational challenges:
    </p>

    <div class="pain-point">
        <div class="icon">&#9888;</div>
        <div>
            <p><strong>Data collection bottleneck:</strong> Gathering safety data from multiple global sources (safety database, clinical trial databases, literature, regulatory intelligence) requires coordination across departments and geographies. Data extraction alone can take 4-6 weeks.</p>
        </div>
    </div>

    <div class="pain-point">
        <div class="icon">&#9888;</div>
        <div>
            <p><strong>Manual narrative writing:</strong> Individual case narratives, signal summaries, and the integrated benefit-risk analysis are written manually by medical writers and safety physicians. A single PBRER may contain 50-200 pages of narrative text.</p>
        </div>
    </div>

    <div class="pain-point">
        <div class="icon">&#9888;</div>
        <div>
            <p><strong>Review and revision cycles:</strong> Multi-layered review processes involving safety physicians, regulatory affairs, medical affairs, and senior management typically require 3-5 revision cycles, each adding 1-2 weeks to the timeline.</p>
        </div>
    </div>

    <div class="pain-point">
        <div class="icon">&#9888;</div>
        <div>
            <p><strong>Inconsistency across products:</strong> When different teams prepare PBRERs for different products, inconsistencies in analytical approach, writing style, and depth of assessment are common, creating regulatory risk.</p>
        </div>
    </div>

    <div class="pain-point">
        <div class="icon">&#9888;</div>
        <div>
            <p><strong>Version control challenges:</strong> With multiple contributors and reviewers, maintaining document integrity and tracking changes becomes increasingly complex, particularly when parallel review streams are required to meet deadlines.</p>
        </div>
    </div>

    <h2>3. AI-Driven Automation Approach</h2>

    <p>
        ArcaScience's PBRER automation platform addresses each of these pain points through an integrated AI pipeline that automates data collection, analysis, narrative generation, and quality assurance:
    </p>

    <div class="solution-point">
        <div class="icon">&#10003;</div>
        <div>
            <p><strong>Automated data extraction:</strong> Direct API connections to safety databases (Argus, ArisG, AERS), clinical trial management systems, and literature databases enable automated data extraction within hours of the data lock point.</p>
        </div>
    </div>

    <div class="solution-point">
        <div class="icon">&#10003;</div>
        <div>
            <p><strong>AI-generated narratives:</strong> Large language models trained on pharmacovigilance writing standards generate draft narratives for case summaries, signal evaluations, and benefit-risk assessments. These drafts are calibrated to match the company's writing conventions and regulatory submission standards.</p>
        </div>
    </div>

    <div class="solution-point">
        <div class="icon">&#10003;</div>
        <div>
            <p><strong>Automated tabulations:</strong> Summary tabulations of adverse reactions by system organ class, seriousness, and outcome are generated automatically with cross-checks against source data for accuracy.</p>
        </div>
    </div>

    <div class="solution-point">
        <div class="icon">&#10003;</div>
        <div>
            <p><strong>Integrated benefit-risk analysis:</strong> The platform automatically updates the product's MCDA-based benefit-risk model with new data from the reporting interval, generating the quantitative benefit-risk section with current evidence.</p>
        </div>
    </div>

    <div class="solution-point">
        <div class="icon">&#10003;</div>
        <div>
            <p><strong>Intelligent review workflow:</strong> AI-assisted review highlights areas requiring expert attention, flags inconsistencies between sections, and ensures compliance with ICH E2C(R2) content requirements.</p>
        </div>
    </div>

    <h2>4. Data Pipeline Architecture</h2>

    <p>
        The automation platform operates through a structured data pipeline that ensures data integrity, traceability, and regulatory compliance at every stage:
    </p>

    <div class="pipeline-diagram">
        <div class="pipeline-step">Data Lock<br>Point</div>
        <span class="pipeline-arrow">&rarr;</span>
        <div class="pipeline-step">Automated<br>Extraction</div>
        <span class="pipeline-arrow">&rarr;</span>
        <div class="pipeline-step">Data<br>Validation</div>
        <span class="pipeline-arrow">&rarr;</span>
        <div class="pipeline-step">AI Analysis<br>& Drafting</div>
        <span class="pipeline-arrow">&rarr;</span>
        <div class="pipeline-step">Expert<br>Review</div>
        <span class="pipeline-arrow">&rarr;</span>
        <div class="pipeline-step">Final<br>Assembly</div>
    </div>

    <h3>4.1 Data Extraction Layer</h3>
    <p>
        The platform connects to source systems through validated API integrations, extracting structured data (case demographics, MedDRA-coded events, reporter information) and unstructured data (case narratives, medical histories). Data are extracted according to predefined specifications that map to PBRER content requirements, ensuring completeness while filtering irrelevant information.
    </p>

    <h3>4.2 Data Harmonization</h3>
    <p>
        Data from different sources use different coding standards, date formats, and terminology. The harmonization layer standardizes all inputs to a common data model, reconciles duplicates, and applies quality rules to flag potential data quality issues. MedDRA coding is validated and, where necessary, recoded to the current version.
    </p>

    <h3>4.3 Analytical Engine</h3>
    <p>
        The analytical engine performs all standard PBRER analyses automatically:
    </p>
    <ul>
        <li>Exposure calculations from multiple data sources (clinical trial subject-years, estimated market exposure from sales/prescription data)</li>
        <li>Incidence rate calculations with confidence intervals for key adverse events</li>
        <li>Disproportionality analyses against reference databases</li>
        <li>Temporal trend analyses comparing current interval to previous intervals</li>
        <li>Subgroup analyses by age, gender, indication, and geographic region</li>
        <li>Signal evaluation using pre-defined criteria and AI-assisted assessment</li>
    </ul>

    <h3>4.4 Narrative Generation</h3>
    <p>
        AI-generated narratives follow templates calibrated to regulatory expectations and company-specific writing standards. The system generates:
    </p>
    <ul>
        <li>Individual case narratives with appropriate level of clinical detail</li>
        <li>Signal summary narratives with evidence evaluation and assessment conclusions</li>
        <li>Benefit-risk assessment narrative integrating quantitative analysis results</li>
        <li>Executive summary and conclusions sections</li>
    </ul>

    <h2>5. Quality Assurance and Validation</h2>

    <h3>5.1 Automated Quality Checks</h3>
    <p>
        The platform performs over 200 automated quality checks across the generated PBRER, including:
    </p>
    <ul>
        <li>Data consistency between narrative text and tabulated data</li>
        <li>Completeness verification against ICH E2C(R2) content requirements</li>
        <li>Cross-reference validation between sections</li>
        <li>Terminology consistency (MedDRA terms, product names, dosage forms)</li>
        <li>Regulatory compliance checks for jurisdiction-specific requirements</li>
        <li>Comparison with previous PBRER to identify gaps or inconsistencies in approach</li>
    </ul>

    <h3>5.2 Human-in-the-Loop Review</h3>
    <p>
        While AI automation handles the bulk of data processing and draft generation, expert review remains essential. The platform structures the review process to maximize reviewer efficiency:
    </p>
    <ul>
        <li><strong>Prioritized review queue:</strong> AI highlights sections requiring the most expert attention based on complexity, novelty, and regulatory sensitivity</li>
        <li><strong>Track changes integration:</strong> All AI-generated content is clearly marked, with source data references linked for easy verification</li>
        <li><strong>Collaborative review:</strong> Multiple reviewers can work simultaneously on different sections with real-time conflict detection</li>
    </ul>

    <h2>6. Compliance with ICH E2C(R2)</h2>

    <p>
        The platform is designed from the ground up for ICH E2C(R2) compliance, with built-in safeguards at every stage:
    </p>

    <table>
        <thead>
            <tr>
                <th>ICH E2C(R2) Requirement</th>
                <th>Platform Compliance Mechanism</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>Worldwide marketing authorization status</td>
                <td>Automated extraction from regulatory intelligence databases, with manual verification step</td>
            </tr>
            <tr>
                <td>Actions taken for safety reasons</td>
                <td>Regulatory action tracking module with audit trail</td>
            </tr>
            <tr>
                <td>Estimated exposure</td>
                <td>Multi-source exposure calculation engine with documented methodology</td>
            </tr>
            <tr>
                <td>Summary tabulations</td>
                <td>Automated generation from validated safety database queries</td>
            </tr>
            <tr>
                <td>Signal and risk evaluation</td>
                <td>Integrated signal detection and evaluation workflow with complete documentation</td>
            </tr>
            <tr>
                <td>Benefit-risk analysis</td>
                <td>MCDA-based quantitative BRA with automated narrative generation</td>
            </tr>
            <tr>
                <td>Audit trail</td>
                <td>Full traceability from source data to final document, including all AI processing steps</td>
            </tr>
        </tbody>
    </table>

    <h2>7. ROI Analysis</h2>

    <div class="metrics-row">
        <div class="metric-box">
            <div class="number">75%</div>
            <div class="label">Reduction in<br>preparation time</div>
        </div>
        <div class="metric-box">
            <div class="number">$680K</div>
            <div class="label">Savings per PBRER<br>(average)</div>
        </div>
        <div class="metric-box">
            <div class="number">92%</div>
            <div class="label">First-pass quality<br>compliance rate</div>
        </div>
    </div>

    <table>
        <thead>
            <tr>
                <th>Cost Category</th>
                <th>Manual Process</th>
                <th>ArcaScience Automated</th>
                <th>Savings</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>Data collection & extraction</td>
                <td>$120K (4-6 weeks)</td>
                <td>$15K (1-2 days)</td>
                <td>87%</td>
            </tr>
            <tr>
                <td>Analysis & tabulations</td>
                <td>$95K (3-4 weeks)</td>
                <td>$10K (automated)</td>
                <td>89%</td>
            </tr>
            <tr>
                <td>Narrative writing</td>
                <td>$180K (4-6 weeks)</td>
                <td>$45K (AI draft + expert review)</td>
                <td>75%</td>
            </tr>
            <tr>
                <td>Review cycles</td>
                <td>$150K (3-4 weeks)</td>
                <td>$50K (1-2 weeks)</td>
                <td>67%</td>
            </tr>
            <tr>
                <td>QC & finalization</td>
                <td>$55K (1-2 weeks)</td>
                <td>$20K (automated QC + final review)</td>
                <td>64%</td>
            </tr>
            <tr>
                <td><strong>Total per PBRER</strong></td>
                <td><strong>$600K-$1.2M</strong></td>
                <td><strong>$140K-$320K</strong></td>
                <td><strong>70-75%</strong></td>
            </tr>
        </tbody>
    </table>

    <p>
        For a company with 15 marketed products requiring annual or semi-annual PBRERs, the annual savings from automation are estimated at <strong>$6-10 million</strong>, with additional value from improved quality, reduced regulatory risk, and reallocation of pharmacovigilance professionals to higher-value activities such as signal evaluation and risk management.
    </p>

    <div class="cta-section">
        <h3>Transform Your Periodic Safety Reporting</h3>
        <p>Learn how ArcaScience can reduce your PBRER preparation time by 75% while improving quality and compliance.</p>
        <p style="margin-top: 15px; margin-bottom: 0;">
            <a class="cta-link" href="https://arcascience.ai/contact">Schedule a Demo</a> &nbsp;|&nbsp;
            <a class="cta-link" href="mailto:info@arcascience.ai">info@arcascience.ai</a>
        </p>
    </div>

</div>

<div class="page-footer">
    &copy; 2026 ArcaScience. All rights reserved. | arcascience.ai<br>
    This document is provided for informational purposes only. ROI estimates are based on industry benchmarks and aggregated client data.
</div>

</body>
</html>
